Cristina Cellurale in Taunton, Massachusetts

Medical School: University Of Massachusetts Medical School
Graduation Year: 2012
The Primary Medical Specialty for Cristina Cellurale is listed as: Hematology/oncology
Approximate Years of Experience: 13
PAC (PECOS ID)#: 3375760895
NPI #: 1154681146
NPI Created On: 05/23/2012
NPI Last Updated Listed as: 02/12/2021
Primary Taxonomy Code: 207R00000X
License Number:
LP02553
Listed Gender: Female

Forms of insurance accepted by include, but are not limited to:

• Harvard Pilgrim Health Care Inc.
• Medicare

They are listed as accepting new patients.

Services and Procedures include:

1. Insertion of needle into vein for collection of blood sample
2. Vaccine for influenza for injection into muscle
3. Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour
4. Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour
5. Injection beneath the skin or into muscle for therapy, diagnosis, or prevention
6. Injection of different drug or substance into a vein for therapy, diagnosis, or prevention
7. Infusion of chemotherapy into a vein up to 1 hour
8. Infusion of different chemotherapy drug or substance into a vein up to 1 hour
9. New patient office or other outpatient visit, typically 30 minutes
10. New patient office or other outpatient visit, typically 45 minutes
11. New patient office or other outpatient visit, typically 60 minutes
12. Established patient office or other outpatient visit, typically 5 minutes
13. Established patient office or other outpatient visit, typically 15 minutes
14. Established patient office or other outpatient, visit typically 25 minutes
15. Established patient office or other outpatient, visit typically 40 minutes
16. Initial hospital inpatient care, typically 70 minutes per day
17. Physician telephone patient service, 5-10 minutes of medical discussion
18. Physician telephone patient service, 11-20 minutes of medical discussion
19. Physician telephone patient service, 21-30 minutes of medical discussion
20. Administration of influenza virus vaccine